Bimolecular complex between rolling and firm adhesion receptors required for cell arrest: CD44 association with VLA-4 in T cell extravasation

Immunity

Volumn 20, Issue 4, 2004, Pages 455-465

  Nandi, Animesh ^a   Estess, Pila ^a   Siegelman, Mark ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL CELL; ARTICLE; CYTOPLASM; EXTRAVASATION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; LYMPH NODE CELL; LYMPHOBLASTOID CELL; LYMPHOCYTE HOMING; LYMPHOMA CELL; MODEL; MOUSE; MYELOMONOCYTIC LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOMA;

ANIMALS; ANTIGENS, CD44; BLOTTING, WESTERN; CELL ADHESION; CELL LINE; CELL MOVEMENT; CYTOCHALASIN D; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INTEGRIN ALPHA4BETA1; LEUKOCYTE ROLLING; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, INBRED BALB C; NUCLEIC ACID SYNTHESIS INHIBITORS; PRECIPITIN TESTS; T-LYMPHOCYTES; TRANSFECTION;

EID: 1842633889     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(04)00077-9     Document Type: Article

References (47)

1. Alon R., Kassner P.D., Carr M.W., Finger E.B., Hemler M.E., Springer T.A. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128:1995;1243-1253.
2. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Jr. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
3. Baron J.L., Reich E.P., Visintin I., Janeway C.A. Jr. The pathogenesis of adoptive murine autoimmune diabetes requires an interaction between alpha 4-integrins and vascular cell adhesion molecule-1. J. Clin. Invest. 93:1994;1700-1708.
4. Brocke S., Piercy C., Steinman L., Weissman I.L., Veromaa T. Antibodies to CD44 and integrin alpha(4), but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl. Acad. Sci. USA. 96:1999;6896-6901.
5. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 272:1996;60-66.
6. Catalina M.D., Estess P., Siegelman M.H. Selective requirements for leukocyte adhesion molecules in models of acute and chronic cutaneous inflammation. participation of E- and P- but not L-selectin Blood. 93:1999;580-589.
7. de Belder A.N., Wik K.O. Preparation and properties of fluorescein-labeled hyaluronate. Carbohydr. Res. 44:1975;251-257.
8. DeGrendele H.C., Estess P., Picker L.J., Siegelman M.H. CD44 and its ligand hyaluronate mediate rolling under physiologic flow. a novel lymphocyte/endothelial cell primary adhesion pathway J. Exp. Med. 183:1996;1119-1130.
9. DeGrendele H.C., Estess P., Siegelman M.H. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J. Immunol. 159:1997;2549-2553. a.
10. DeGrendele H.D., Estess P., Siegelman M.H. Requirement for CD44 in activated T cell extravasation into an inflamed site. Science. 278:1997;672-675. b.
11. Dianzani U., Bragardo M., Tosti A., Ruggeri L., Volpi I., Casucci M., Bottarel F., Feito M.J., Bonissoni S., Velardi A. CD44 signaling through p56(lck) involves lateral association with CD4 in human CD4(+) T cells. Int. Immunol. 11:1999;1085-1092.
12. Estess P., DeGrendele H.C., Pascual V., Siegelman M.H. Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity. J. Clin. Invest. 102:1998;1173-1182.
13. Estess P., Nandi A., Mohamadzadeh M., Siegelman M.H. IL-15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44 dependent pathway in vivo. J. Exp. Med. 190:1999;9-19.
14. Forlow S.B., White E.J., Barlow S.C., Feldman S.H., Lu H., Bagby G.J., Beaudet A.L., Bullard D.C., Ley K. Severe inflammatory defect and reduced viability in CD18 and E-selectin double-mutant mice. J. Clin. Invest. 106:2000;1457-1466.
15. Ghosh S., Goldin E., Gordon F.H., Malchow H.A., Rask-Madsen J., Rutgeerts P., Vyhnalek P., Zadorova Z., Palmer T., Donoghue S. Natalizumab for active Crohn's disease. N. Engl. J. Med. 348:2003;24-32.
16. Holzmann B., McIntyre B.W., Weissman I.L. Identification of a murine Peyer's patch-specific lymphocyte homing receptor as an integrin molecule with an alpha chain homologous to human VLA-4 alpha. Cell. 56:1989;37-46.
17. Ilangumaran S., Briol A., Hoessli D.C. Cd44 selectively associates with active src family protein tyrosine kinases lck and fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes. Blood. 91:1998;3901-3908.
18. Jung U., Norman K.E., Scharffetterkochanek K., Beaudet A.L., Ley K. Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J. Clin. Invest. 102:1998;1526-1533.
19. Kadono T., Venturi G.M., Steeber D.A., Tedder T.F. Leukocyte rolling velocities and migration are optimized by cooperative L-selectin and intercellular adhesion molecule-1 functions. J. Immunol. 169:2002;4542-4550.
20. Kucik D.F., Dustin M.L., Miller J.M., Brown E.J. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J. Clin. Invest. 97:1996;2139-2144.
21. Labeta M.O., Fernandez N., Festenstein H. Solubilisation effect of Nonidet P-40, triton X-100 and CHAPS in the detection of MHC-like glycoproteins. J. Immunol. Methods. 112:1988;133-138.
22. Laffon A., Garcia-Vicuna R., Humbria A., Postigo A.A., Corbi A.L., de Landazuri M.O., Sanchez-Madrid F. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J. Clin. Invest. 88:1991;546-552.
23. Legg J.W., Isacke C.M. Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, cd44. Curr. Biol. 8:1998;705-708.
24. Lesley J., He Q., Miyake K., Hamann A., Hyman R., Kincade P.W. Requirements for hyaluronic acid binding by CD44. a role for the cytoplasmic domain and activation by antibody J. Exp. Med. 175:1992;257-266.
25. Lesley J., Howes N., Perschl A., Hyman R. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med. 180:1994;383-387.
26. Lesley J., English N., Charles C., Hyman R. The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding. Eur. J. Immunol. 30:2000;245-253.
27. Liu D., Sy M.S. A cysteine residue located in the transmembrane domain of cd44 is important in binding of cd44 to hyaluronic. J. Exp. Med. 183:1996;1987-1994.
28. Lokeshwar V.B., Fregien N., Bourguignon L.Y. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol. 126:1994;1099-1109.
29. Mikecz K., Brennan F.R., Kim J.H., Glant T.T. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat. Med. 1:1995;558-563.
30. Miller D.H., Khan O.A., Sheremata W.A., Blumhardt L.D., Rice G.P.A., Libonati M.A., Willmer-Hulme A.J., Dalton C.M., Miszkiel K.A., O'Connor P.W. A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348:2003;15-23.
31. Mohamadzadeh M., DeGrendele H.C., Estess P., Siegelman M.H. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA dependent primary adhesion. J. Clin. Invest. 101:1998;97-108.
32. Neame S.J., Isacke C.M. Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells. EMBO J. 11:1992;4733-4738.
33. Perschl A., Lesley J., English N., Trowbridge I., Hyman R. Role of CD44 cytoplasmic domain in hyaluronan binding. Eur. J. Immunol. 25:1995;495-501.
34. Protin U., Schweighoffer T., Jochum W., Hilberg F. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J. Immunol. 163:1999;4917-4923.
35. Pure E., Camp R.L., Peritt D., Panettieri R.A., Lazaar A.L., Nayak S. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 181:1995;55-62.
36. Schmits R., Filmus J., Gerwin N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J.et al. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood. 90:1997;2217-2233.
37. Siegelman M.H., Stanescu D., Estess P.E. The CD44 initiated pathway of T cell extravasation utilizes VLA-4, not LFA-1, for firm adhesion. J. Clin. Invest. 105:2000;683-691.
38. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration. the multistep paradigm Cell. 76:1994;301-314.
39. Thomas L., Byers H.R., Vink J., Stamenkovic I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol. 118:1992;971-977.
40. Tsukita S., Oishi K., Sato N., Sagara J., Kawai A. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:1994;391-401.
41. Uff C.R., Neame S.J., Isacke C.M. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur. J. Immunol. 25:1999;1883-1887.
42. van Dinther-Janssen A.C., Horst E., Koopman G., Newmann W., Scheper R.J., Meijer C.J., Pals S.T. The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. J. Immunol. 147:1991;4207-4210.
43. Visweswariah S.S., Ramachandran V., Ramamohan S., Das G., Ramachandran J. Characterization and partial purification of the human receptor for the heat-stable enterotoxin. Eur. J. Biochem. 219:1994;727-736.
44. Weiss L., Slavin S., Reich S., Cohen P., Shuster S., Stern R., Kaganovsky E., Okon E., Rubinstein A.M., Naor D. Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc. Natl. Acad. Sci. USA. 97:2000;285-290.
45. Yago T., Leppanen A., Qiu H., Marcus W.D., Nollert M.U., Zhu C., Cummings R.D., McEver R.P. Distinct molecular and cellular contributions to stabilizing selectin-mediated rolling under flow. J. Cell Biol. 158:2002;787-799.
46. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature. 356:1992;63-66.
47. Yonemura S., Hirao M., Doi Y., Takahashi N., Kondo T., Tsukita S. Ezrin/radixin/moesin (erm) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of cd44, cd43, and icam-2. J. Cell Biol. 140:1998;885-895.